Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22607866 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe
Conditions: Coronary Disease;   Coronary Artery Disease;   Coronary Restenosis
Intervention: Device: XIENCE V® Everolimus Eluting Coronary Stent

Indicates status has not been verified in more than two years